Advertisement
lupin

Lupin

 

More Stories on Lupin
Top stocks in news: BEL, Gujarat Kidney, Grasim, Lupin, RVNL, Waaree, NTPC Green, Afcons

Top stocks in news: BEL, Gujarat Kidney, Grasim, Lupin, RVNL, Waaree, NTPC Green, Afcons

Dec 30, 2025, 07:50 AM IST

Stocks including Bharat Electronics, Gujarat Kidney, Grasim, Lupin, Waaree Energies, NTPC Green, Afcons Infra, Timex India and more will be in the spotlight on Tuesday, December 30.

Lupin doubles down on complex drugs to extend growth run

Lupin doubles down on complex drugs to extend growth run

Dec 22, 2025, 09:11 PM IST

Vinita Gupta, CEO at Lupin told Business Today that the company’s strategy is centred on high-barrier products, operational efficiency and selective expansion across key markets.

For Lupin’s Vinita Gupta leadership is all about consistency, trust and belief in her team

For Lupin’s Vinita Gupta leadership is all about consistency, trust and belief in her team

Dec 19, 2025, 03:10 PM IST

The path to the top is rarely smooth, but Lupin's Vinita Gupta says women leaders must lead with conviction and a global mindset

Top stocks in news: ICICI AMC, RIL, Airtel, HCLTech, BPCL, Vodafone, Lupin, IndiGo, Swiggy

Top stocks in news: ICICI AMC, RIL, Airtel, HCLTech, BPCL, Vodafone, Lupin, IndiGo, Swiggy

Dec 19, 2025, 06:50 AM IST

Stocks including ICICI Pru AMC, RIL, Airtel, HCL Tech, BPCL, Voda Idea, Lupin, IndiGo, Biocon, Bharti Hexacom, Swiggy and more will be in the spotlight on Friday, December 19.

Top stocks in news: Nephrocare, RIL, Park Medi, Akzo Nobel, IOB, Vedanta, NBCC, Ola, RVNL

Top stocks in news: Nephrocare, RIL, Park Medi, Akzo Nobel, IOB, Vedanta, NBCC, Ola, RVNL

Dec 17, 2025, 06:57 AM IST

Stocks including Nephrocare, Reliance, Park Medi, Akzo Nobel, Indian Overseas Bank, Vedanta, NBCC, Ola Electric, RVNL, Zaggle Prepaid and more will be in the spotlight on Wednesday, December 17.

Lupin shares in news as firm's cancer injection gets USFDA nod, more details

Lupin shares in news as firm's cancer injection gets USFDA nod, more details

Dec 01, 2025, 09:14 AM IST

Lupin has received USFDA approval for its biosimilar Armlupeg (pegfilgrastim-unne) injection, to be manufactured at its Pune facility.

Lupin banks on complex generics, speciality products to sustain growth in FY26–27

Lupin banks on complex generics, speciality products to sustain growth in FY26–27

Nov 11, 2025, 12:17 PM IST

The United States market remains the company’s strongest growth driver, contributing 40% of total sales and rising 47% year-on-year to ₹2,762 crore.

Top stocks in news: Lenskart, Bajaj Auto, HAL, Trent, Nykaa, Nalco, Swiggy, Lupin, Medanta

Top stocks in news: Lenskart, Bajaj Auto, HAL, Trent, Nykaa, Nalco, Swiggy, Lupin, Medanta

Nov 10, 2025, 08:20 AM IST

Stocks including Lenskart, Bajaj Auto, Hindustan Aeronautics, Trent, Nykaa, National Aluminium, Swiggy, Lupin, Anant Raj, Medanta and more will be in the spotlight on Monday, November 10.

Lupin Defies Tariff Headwinds — U.S. Market Drives Q2 Gains

Lupin Defies Tariff Headwinds — U.S. Market Drives Q2 Gains

Nov 07, 2025, 02:19 PM IST

Lupin reported a 24% year-on-year rise in Q2FY26 revenue to ₹6,831 crore, led by strong growth in the U.S. and emerging markets. EBITDA rose 76% to ₹2,431 crore with margins improving to 35.6%. Profit after tax stood at ₹1,485 crore, up 73% YoY. The company received six ANDA approvals and launched six new products in the U.S. Lupin remains the third-largest generic player in the U.S. and has turned net cash positive.

Top stocks in news: Studds, Airtel, Maruti Suzuki, ABB India, TVS Motor, RVNL, Lupin, NHPC

Top stocks in news: Studds, Airtel, Maruti Suzuki, ABB India, TVS Motor, RVNL, Lupin, NHPC

Nov 07, 2025, 08:29 AM IST

Stocks including Studds Accessories, Bharti Airtel, Maruti Suzuki, ABB India, TVS Motor Company, RVNL, Lupin, NHPC and more will be in the spotlight on Friday, November 07.

Pharma stocks in focus as Trump eyes probe into foreign drug pricing practices

Pharma stocks in focus as Trump eyes probe into foreign drug pricing practices

Oct 23, 2025, 08:42 AM IST

Aurobindo Pharma derives 89 per cent of its revenue from exports, with nearly half (49 per cent) from the US. Similarly, Biocon earns about 46 per cent of its revenue from the American market.